The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria
Abstract
Antimicrobial peptides (AMPs) have been identified as a potentially new class of antibiotics to combat bacterial resistance to conventional drugs. The design of de novo AMPs with high therapeutic indexes, low cost of synthesis, high resistance to proteases and high bioavailability remains a challenge. Such design requires computational modeling of antimicrobial properties. Currently, most computational methods cannot accurately calculate antimicrobial potency against particular strains of bacterial pathogens. We developed a tool for AMP prediction (Special Prediction (SP) tool) and made it available on our Web site (https://dbaasp.org/prediction). Based on this tool, a simple algorithm for the design of de novo AMPs (DSP) was created. We used DSP to design short peptides with high therapeutic indexes against gram-negative bacteria. The predicted peptides have been synthesized and tested in vitro against a panel of gram-negative bacteria, including drug resistant ones. Predicted activity against Escherichia coli ATCC 25922 was experimentally confirmed for 14 out of 15 peptides. Further improvements for designed peptides included the synthesis of D-enantiomers, which are traditionally used to increase resistance against proteases. One synthetic D-peptide (SP15D) possesses one of the lowest values of minimum inhibitory concentration (MIC) among all DBAASP database short peptides at the time of the submission of this article, while being highly stable against proteases and having a high therapeutic index. The mode of anti-bacterial action, assessed by fluorescence microscopy, shows that SP15D acts similarly to cell penetrating peptides. SP15D can be considered a promising candidate for the development of peptide antibiotics. We plan further exploratory studies with the SP tool, aiming at finding peptides which are active against other pathogenic organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
CAMP R3 : a database on sequences, structures and signatures of antimicrobial peptides: Table 1.
Waghu, F. H., Barai, R. S., Gurung, P., & Idicula-Thomas, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1051 · Cited by 715
Research works printed but not linked: 72
- Masi, 2005, Inhibitors of efflux pumps in Gram-negative bacteria, Trends Mol. Med., 11, 382, 10.1016/j.molmed.2005.06.006 · DOI · Paper page
- Pirtskhalava, 2016, DBAASP v.2: An Enhanced Database of Structure and Antimicrobial/Cytotoxic Activity of Natural and Synthetic Peptides, Nucl. Acids Res., 44, D1104, 10.1093/nar/gkv1174 · DOI · Paper page
- Greber, 2017, Antimicrobial Peptides Under Clinical Trials, Curr. Top. Med. Chem., 17, 620, 10.2174/1568026616666160713143331 · DOI · Paper page
- Li, 2017, Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design, Front. Neurosci., 11, 73, 10.3389/fnins.2017.00073 · DOI · Paper page
- Grieco, 2011, Alanine scanning analysis and structure–function relationships of the frog-skin antimicrobial peptide temporin-1Ta, J. Pept. Sci., 17, 358, 10.1002/psc.1350 · DOI
- Rausch, 2013, Alanine scan of the peptide antibiotic feglymycin: Assessment of amino acid side chains contributing to antimicrobial activity, ChemBioChem, 14, 625, 10.1002/cbic.201300032 · DOI
- Fjell, 2011, Designing Antimicrobial Peptides: Form Follows Function, Nat. Rev. Drug Discov., 11, 37, 10.1038/nrd3591 · DOI · Paper page
- Torrent, 2012, AMPA: An Automated Web Server for Prediction of Protein Antimicrobial Regions, Bioinformatics, 28, 130, 10.1093/bioinformatics/btr604 · DOI · Paper page
- Jenssen, 2007, Evaluating Different Descriptors for Model Design of Antimicrobial Peptides with Enhanced Activity toward P. aeruginosa, Chem. Biol. Drug. Des., 70, 134, 10.1111/j.1747-0285.2007.00543.x · DOI
- Taboureau, 2006, Design of Novispirin Antimicrobial Peptides by Quantitative Structure-Activity Relationship, Chem. Biol. Drug Des., 68, 48, 10.1111/j.1747-0285.2006.00405.x · DOI
- Wang, 2016, Spontaneous formation of structurally diverse membrane channel architectures from a single antimicrobial peptide, Nat. Commun., 7, 13535, 10.1038/ncomms13535 · DOI
- Li, 2015, A novel fragment based strategy for membrane active antimicrobials against MRSA, Biochim. Biophys. Acta Biomembr., 1848, 1023, 10.1016/j.bbamem.2015.01.001 · DOI
- Li, 2013, Molecular simulations suggest how a branched antimicrobial peptide perturbs a bacterial membrane and enhances permeability, Biochim. Biophys. Acta Biomembr., 1828, 1112, 10.1016/j.bbamem.2012.12.015 · DOI
- Fox, 2016, The multifaceted roles of molecular dynamics simulations in drug discovery, Curr. Pharm. Des., 22, 3585, 10.2174/1381612822666160425120507 · doi:10.2174/1381612822666160425120507
- Saravanan, 2014, Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility, Biotechnol. Bioeng., 111, 37, 10.1002/bit.25003 · DOI
- Mohanram, 2014, b-boomerang antimicrobial and antiendotoxic peptides: Lipidation and disulfide bond effects on activity and structure, Pharmaceuticals, 7, 482, 10.3390/ph7040482 · doi:10.3390/ph7040482
- Jeong, 2016, NMR structural studies of antimicrobial peptides: LPcin analogs, Biophys. J., 110, 423, 10.1016/j.bpj.2015.12.006 · doi:10.1016/j.bpj.2015.12.006
- Jenssen, 2008, QSAR Modeling and Computer-Aided Design of Antimicrobial Peptides, J. Pept. Sci., 14, 110, 10.1002/psc.908 · DOI
- Fjell, 2009, Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning, J. Med. Chem., 52, 2006, 10.1021/jm8015365 · DOI · Paper page
- Cherkasov, 2009, Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad Spectrum of Highly Antibiotic-Resistant Superbugs, ACS Chem. Biol., 4, 65, 10.1021/cb800240j · DOI · Paper page
- Torrent, M., Andreu, D., Nogues, V.M., and Boix, E. (2011). Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model. PLoS ONE, 6. · DOI · Paper page
- Mooney, 2013, Peptidelocator: Prediction of Bioactive Peptides in Protein Sequences, Bioinformatics, 29, 1120, 10.1093/bioinformatics/btt103 · DOI
- Porto, W.F., Pires, A.S., and Franco, O.L. (2012). Cs-Amppred: An Updated SVM Model for Antimicrobial Activity Prediction in Cysteine-Stabilized Peptides. PLoS ONE, 7. · DOI
- Ng, 2015, Prediction of Antimicrobial Peptides Based on Sequence Alignment and Support Vector Machine-Pairwise Algorithm Utilizing LZ-Complexity, Biomed. Res. Int., 2015, 212715, 10.1155/2015/212715 · DOI
- Khosravian, 2013, Predicting Antibacterial Peptides by the Concept of Chou’s Pseudo-Amino Acid Composition and Machine Learning Methods, Protein Pept. Lett., 20, 180, 10.2174/092986613804725307 · doi:10.2174/092986613804725307
- Meher, 2017, Predicting Antimicrobial Peptides with Improved Accuracy by Incorporating the Compositional, Physico-Chemical and Structural Features into Chou’s General PseAAC, Sci. Rep., 7, 42362, 10.1038/srep42362 · DOI · Paper page
- Lira, 2013, Prediction of Antimicrobial Activity of Synthetic Peptides by a Decision Tree Model, Appl. Environ. Microbiol., 79, 3156, 10.1128/AEM.02804-12 · doi:10.1128/aem.02804-12
- Khamis, 2015, Distinct Profiling of Antimicrobial Peptide Families, Bioinformatics, 31, 849, 10.1093/bioinformatics/btu738 · DOI
- Xiao, 2013, Iamp-2l: A Two-Level Multi-Label Classifier for Identifying Antimicrobial Peptides and Their Functional Types, Anal. Biochem., 436, 168, 10.1016/j.ab.2013.01.019 · DOI · Paper page
- Maccari, G., Di Luca, M., Nifosí, R., Cardarelli, F., Signore, G., Boccardi, C., and Bifone, A. (2013). Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization. PLoS Comput. Biol., 9. · DOI
- Bhadra, 2018, AmPEP: Sequence-based Prediction of Antimicrobial Peptides using Distribution Patterns of Amino Acid Properties and Random Forest, Sci. Rep., 8, 1697, 10.1038/s41598-018-19752-w · DOI · Paper page
- Youmans, M., Spainhour, C., and Qiu, P. (2017, January 13–16). Long Short-Term Memory Recurrent Neural Networks for Antibacterial Peptide Identification. Proceedings of the 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Kansas City, MO, USA. · DOI
- Juretic, 2009, Computational Design of Highly Selective Antimicrobial Peptides, J. Chem. Inf. Model., 49, 2873, 10.1021/ci900327a · DOI
- Wang, P., Hu, L., Liu, G., Jiang, N., Chen, X., Xu, J., Zheng, W., Li, L., Tan, M., and Chen, Z. (2011). Prediction of Antimicrobial Peptides Based on Sequence Alignment and Feature Selection Methods. PLoS ONE, 6. · DOI · Paper page
- Melo, M.N., Ferre, R., Feliu, L., Bardaji, E., Planas, M., and Castanho, M.A. (2011). Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides. PLoS ONE, 6. · DOI
- Freire, 2015, Mining Viral Proteins for Antimicrobial and Cell-Penetrating Drug Delivery Peptides, Bioinformatics, 31, 2252, 10.1093/bioinformatics/btv131 · DOI
- Chang, K.Y., Lin, T.P., Shih, L.Y., and Wang, C.K. (2015). Analysis and Prediction of the Critical Regions of Antimicrobial Peptides Based on Conditional Random Fields. PLoS ONE, 10. · DOI
- Toropova, 2015, QSAR Modeling of the Antimicrobial Activity of Peptides as a Mathematical Function of a Sequence of Amino Acids, Comput. Biol. Chem., 59, 126, 10.1016/j.compbiolchem.2015.09.009 · DOI
- Toropov, 2012, QSAR Modeling of Endpoints for Peptides Which Is Based on Representation of the Molecular Structure by a Sequence of Amino Acids, Struct. Chem., 23, 1891, 10.1007/s11224-012-9995-0 · DOI
- Lata, S., Sharma, B.K., and Raghava, G.P. (2007). Analysis and Prediction of Antibacterial Peptides. BMC Bioinf., 8. · DOI · Paper page
- Lata, S., Mishra, N.K., and Raghava, G.P. (2010). AntiBP2: Improved Version of Antibacterial Peptide Prediction. BMC Bioinf., 11. · DOI · Paper page
- Nagarajan, 2018, Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria, J. Biol. Chem., 293, 3492, 10.1074/jbc.M117.805499 · DOI
- Giraldo, 2018, In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus, Antonie Van Leeuwenhoek, 111, 1871, 10.1007/s10482-018-1080-2 · DOI
- Vishnepolsky, 2018, Predictive model of linear AMPs active against Gram-negative bacteria, J. Chem. Inf. Model., 58, 1141, 10.1021/acs.jcim.8b00118 · DOI
- Vishnepolsky, B., and Pirtskhalava, M. (2019). Comment on: ‘Empirical Comparison of Web-Based Antimicrobial Peptide Prediction Tools’. Bioinformatics. · DOI
- Vishnepolsky, 2014, Prediction of Linear Cationic Antimicrobial Peptides Based on Characteristics Responsible for Their Interaction with the Membranes, J. Chem. Inf. Model., 54, 1512, 10.1021/ci4007003 · DOI
- Nicolau, 2008, Carbapenems: A potent class of antibiotics, Expert Opin. Pharm., 9, 23, 10.1517/14656566.9.1.23 · DOI · Paper page
- Holton, 2013, CPPpred: Prediction of cell penetrating peptides, Bioinformatics, 29, 3094, 10.1093/bioinformatics/btt518 · DOI · Paper page
- Matsuzaki, 1999, Why and how are peptide–lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes, Biochim. Biophys. Acta (BBA) Biomembr., 1462, 1, 10.1016/S0005-2736(99)00197-2 · DOI · Paper page
- Shai, 1999, Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim. Biophys. Acta (BBA) Biomembr., 1462, 55, 10.1016/S0005-2736(99)00200-X · DOI · Paper page
- Yang, 2000, Crystallization of antimicrobial pores in membranes: Mgainin and ptegrin, Biophys. J., 79, 2002, 10.1016/S0006-3495(00)76448-4 · DOI · Paper page
- Brogden, 2005, Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?, Nat. Rev. Microbiol., 3, 238, 10.1038/nrmicro1098 · DOI · Paper page
- Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
- Reddy, 2004, Antimicrobial peptides: Premises and promises, Int. J. Antimicrob. Agents, 24, 536, 10.1016/j.ijantimicag.2004.09.005 · DOI · Paper page
- Otvos, 2000, Antibacterial peptides isolated from insects, J. Pept. Sci., 6, 497, 10.1002/1099-1387(200010)6:10<497::AID-PSC277>3.0.CO;2-W · DOI · Paper page
- Bierbaum, 1998, The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II, Antimicrob. Agents Chemother., 42, 154, 10.1128/AAC.42.1.154 · DOI · Paper page
- Matsuzaki, 1998, Relationship of membrane curvature to the formation of pores by magainin 2, Biochemistry, 37, 11856, 10.1021/bi980539y · DOI · Paper page
- Dagan, 2002, In vitro antiplasmodium effects of dermaseptin S4 derivatives, Antimicrob. Agents Chemother., 46, 1059, 10.1128/AAC.46.4.1059-1066.2002 · DOI
- Matsuzaki, 1996, An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation, Biochemistry, 35, 11361, 10.1021/bi960016v · DOI · Paper page
- Wu, 1999, Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli, Biochemistry, 38, 7235, 10.1021/bi9826299 · DOI · Paper page
- Martins, 2018, Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides, Nat. Microbiol., 3, 718, 10.1038/s41564-018-0164-0 · DOI · Paper page
- Shagaghi, 2017, Revealing the sequence of interactions of PuroA peptide with Candida albicans cells by live-cell imaging, Sci. Rep., 7, 43542, 10.1038/srep43542 · DOI
- Chan, 2006, Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action, Biochim. Biophys. Acta (BBA) Biomembr., 758, 1184, 10.1016/j.bbamem.2006.04.006 · DOI · Paper page
- Patrzykat, 2002, Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrob. Agents Chemother., 46, 605, 10.1128/AAC.46.3.605-614.2002 · DOI · Paper page
- Ester, M., Kriegel, H., Sander, J., and Xu, X. (1996, January 2–4). A density-based algorithm for discovering clusters in large spatial databases with noise. Proceedings of the Second International Conference on Knowledge Discovery and Data Mining (KDD-96), Portland, Oregon.
- Moon, 2011, Side-chain hydrophobicity scale derived from transmembrane protein folding into lipid bilayers, Proc. Natl. Acad. Sci. USA, 108, 10174, 10.1073/pnas.1103979108 · DOI · Paper page
- Senes, 2007, E(z), a Depth-dependent Potential for Assessing the Energies of Insertion of Amino Acid Side-chains into Membranes: Derivation and Applications to Determining the Orientation of Transmembrane and Interfacial Helices, J. Mol. Biol., 366, 436, 10.1016/j.jmb.2006.09.020 · DOI · Paper page
- Uversky, 2000, Why are “natively unfolded” proteins unstructured under physiological conditions?, Proteins Struct. Funct. Gen., 41, 415, 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7 · DOI · Paper page
- Kessel, A., and Ben-Tal, N. (2011). Introduction to Proteins: Structure, Function and Motion (Chapman & Hall/CRC Mathematical and Computational Biology), CRC Press, Taylor & Francis Group. [1st ed.].
- The UniProt Consortium (2015). UniProt: A hub for protein information. Nucleic Acids Res., 43, D204–D212. · DOI · Paper page
- Wang, 2016, APD3: The antimicrobial peptide database as a tool for research and education, Nucleic Acids Res., 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
- Fan, 2016, DRAMP: A comprehensive data repository of antimicrobial peptides, Sci. Rep., 14, 24482, 10.1038/srep24482 · DOI · Paper page
Cited by
Pirtskhalava, M., Amstrong, A. A., Grigolava, M., Chubinidze, M., Alimbarashvili, E., Vishnepolsky, B., Gabrielian, A., Rosenthal, A., Hurt, D. E., & Tartakovsky, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa991 · Cited by 703
Self-citationAccelerated antimicrobial discovery via deep generative models and molecular dynamics simulations
Das, P., Sercu, T., Wadhawan, K., Padhi, I., Gehrmann, S., Cipcigan, F., Chenthamarakshan, V., Strobelt, H., dos Santos, C., Chen, P.-Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00689-x · Cited by 414
Accelerating antibiotic discovery through artificial intelligence
Melo, M. C. R., Maasch, J. R. M. A., & de la Fuente-Nunez, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02586-0 · Cited by 234
Metadata
- Authors
- Vishnepolsky, B., Zaalishvili, G., Karapetian, M., Nasrashvili, T., Kuljanishvili, N., Gabrielian, A., Rosenthal, A., Hurt, D. E., Tartakovsky, M., Grigolava, M., & Pirtskhalava, M.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2019-06-03
- Volume
- 12
- Issue
- 2
- Pages
- 82
- ISSN
- 1424-8247
- Cited by
- 63
- References
- 2
- Language
- en
- Funders
- International Science and Technology Center (G-2102)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria. https://app.cochat.ai/papers/10.3390/ph12020082
- The paper
- Vishnepolsky, B., Zaalishvili, G., Karapetian, M., Nasrashvili, T., Kuljanishvili, N., Gabrielian, A., Rosenthal, A., Hurt, D. E., Tartakovsky, M., Grigolava, M., & Pirtskhalava, M. (2019). De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria. Pharmaceuticals. https://doi.org/10.3390/ph12020082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.